Rituximab Induction Therapy in Intestinal Transplantation: beneficial effects on development of de novo DSA
Background: Development of de novo donor-specific antibodies (DnDSA) is associated with acute cellular rejection (ACR) and graft loss in intestinal transplant (ITX). We assessed the effect of rituximab induction on DnDSA formation.
Authors
- Jang Moon (ORCID: https://orcid.org/0000-0003-3564-6859)
- Thomas D. Schiano (ORCID: https://orcid.org/0000-0003-1878-5101)
- Kishore Iyer (ORCID: https://orcid.org/0000-0002-1446-3271)
- Mohamed Khalaf (ORCID: https://orcid.org/0000-0003-0529-6720)
Institutions
- Mount Sinai Medical Center (US)
Publication Details
- Journal
- Intestinal failure.
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.intf.2025.100116
- Primary Topic
- Clinical Nutrition and Gastroenterology
- Type
- article
- Field-Weighted Citation Impact
- 0.00